RxNorm Semantic Concepts Index - 514
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "514".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 5140 | He - Helium | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 5140 | He - Helium | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 5140 | He - Helium | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 5140 | He - Helium | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 5140 | He - Helium | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 5140 | He - Helium | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 5141 | Helminth protein | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 5141 | Helminth protein | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 51428 | Insulin aspart soluble | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 51428 | Insulin aspart soluble | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 51428 | Insulin aspart soluble | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 51428 | Insulin aspart soluble | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 51428 | Insulin aspart soluble | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 51428 | Insulin aspart soluble | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 51430 | IGF-BP 3 - Insulin-like growth factor binding protein 3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 51430 | IGF-BP 3 - Insulin-like growth factor binding protein 3 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 51430 | IGF-BP 3 - Insulin-like growth factor binding protein 3 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 51441 | Lymphocyte antigen CD50 | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 51441 | Lymphocyte antigen CD50 | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 5146 | Hemagglutinin | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 5146 | Hemagglutinin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 51470 | Iodosorb | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| Concept ID (RxCUI): 51471 | iodoxamid | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 51474 | Iotrolan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 51474 | Iotrolan | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 51474 | Iotrolan | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 51474 | Iotrolan | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 51474 | Iotrolan | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 51486 | iprazochrome | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 51487 | ipriflavone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 51499 | irinotecan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 51499 | irinotecan | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 51499 | irinotecan | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 51499 | irinotecan | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 51499 | irinotecan | Full form of descriptor (FN) | YES |